drugset / Trial / NCT00854685
Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this clinical trial is to establish what dose level and dosing frequency is optimal in the treatment of rheumatoid arthritis patients with ART621.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-12
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PLACULUMAB | Protein / enzyme biologic | 1.5 mg/kg | Intravenous |
| Subject | PLACULUMAB | Protein / enzyme biologic | 3 mg/kg | Intravenous |